BSE - Delayed Quote INR

FDC Limited (FDC.BO)

429.40
-5.35
(-1.23%)
At close: June 6 at 3:29:38 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
--
--
19,351,996
17,778,284
15,233,376
Cost of Revenue
7,564,098
7,362,785
6,842,543
6,837,348
5,474,512
Gross Profit
13,141,105
13,718,419
12,509,453
10,940,936
9,758,864
Operating Expense
--
--
9,523,243
8,818,429
7,591,065
Operating Income
--
--
2,986,210
2,122,507
2,167,799
Net Non Operating Interest Income Expense
260,987
--
263,352
197,288
199,532
Pretax Income
3,691,153
--
3,962,186
2,578,033
2,893,901
Tax Provision
947,174
--
911,599
639,752
732,252
Net Income Common Stockholders
2,743,979
--
3,052,233
1,940,374
2,164,033
Diluted NI Available to Com Stockholders
2,743,979
2,667,881
3,052,233
1,940,374
2,164,033
Basic EPS
16.72
--
18.59
11.67
12.82
Diluted EPS
16.72
--
18.59
11.67
12.82
Basic Average Shares
164,027.78
--
164,216.10
166,219.95
168,810.08
Diluted Average Shares
164,027.78
--
164,216.10
166,219.95
168,810.08
Rent Expense Supplemental
--
--
5,056
1,488
947
Total Expenses
17,939,570
--
16,365,786
15,655,777
13,065,577
Net Income from Continuing & Discontinued Operation
2,743,979
--
3,052,233
1,940,374
2,164,033
Normalized Income
2,262,816.10
--
2,553,897.35
1,818,891.65
1,820,072.55
Interest Income
--
--
303,692
238,161
230,427
Interest Expense
37,781
45,096
35,416
35,715
25,022
Net Interest Income
-45,096
--
263,352
197,288
199,532
EBIT
--
--
3,997,602
2,613,748
2,918,923
EBITDA
4,214,997
--
4,396,764
3,003,142
3,291,944
Reconciled Cost of Revenue
7,564,098
--
6,842,543
6,837,348
5,474,512
Reconciled Depreciation
486,063
--
399,162
389,394
373,021
Net Income from Continuing Operation Net Minority Interest
2,743,979
--
3,052,233
1,940,374
2,164,033
Total Unusual Items Excluding Goodwill
243,009
--
647,252
161,579
460,476
Total Unusual Items
647,252
--
647,252
161,579
460,476
Normalized EBITDA
3,567,745
--
3,749,512
2,841,563
2,831,468
Tax Rate for Calcs
0
--
0
0
0
Tax Effect of Unusual Items
166,089.10
--
148,916.35
40,096.65
116,515.55
3/31/2022 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

JBCHEPHARM.BO J. B. Chemicals & Pharmaceuticals Limited
1,703.35
+0.35%
 
RPGLIFE.NS RPG Life Sciences Limited
2,141.70
-1.27%
 
SOLARA.NS Solara Active Pharma Sciences Limited
474.80
+0.41%
 
HIKAL.NS Hikal Limited
372.35
-0.63%
 
ERIS.NS Eris Lifesciences Limited
1,638.30
-0.82%
 
LAURUSLABS.BO Laurus Labs Limited
641.80
+0.18%
 
SPARC.BO Sun Pharma Advanced Research Company Limited
165.40
+2.07%
 
ALKEM.NS Alkem Laboratories Limited
4,862.50
+0.39%
 
PGHL.NS Procter & Gamble Health Limited
5,560.50
-0.33%
 
PPLPHARMA.NS Piramal Pharma Limited
206.33
-0.84%